WallStreetZenWallStreetZen

NASDAQ: DRMA
Dermata Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Dermata Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DRMA annual revenue was $0.0, with N/A growth year-over-year.

DRMA revenue history

Current Revenue
$0.0
Current Earnings
-$7.6M
Current Profit Margin
0%

Be the first to know when DRMA announces revenue.

DRMA Revenue History By Year

DRMA Yearly RevenueDRMA RevenueDRMA ChangeDRMA Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Dermata Therapeutics Revenue FAQ

What was DRMA's revenue last quarter?

Dermata Therapeutics (NASDAQ: DRMA) reported Q4 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Dermata Therapeutics's revenue was $0.00.

What was Dermata Therapeutics's revenue in 2025?

Dermata Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Dermata Therapeutics make in a day?

Based on Dermata Therapeutics annual revenue for the past five years, DRMA makes an average of $0.00 per day.

What was Dermata Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Dermata Therapeutics's revenue has grown null year over year. Dermata Therapeutics's revenue in the past year totaled $0.00.

How much does Dermata Therapeutics make in a year?

Dermata Therapeutics's revenue by year for the past five years is:
  • Dermata Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
  • Dermata Therapeutics's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
  • Dermata Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Dermata Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Dermata Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.